BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19273678)

  • 1. Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.
    Sáez-Llorens X; Yogev R; Arguedas A; Rodriguez A; Spigarelli MG; De León Castrejón T; Bomgaars L; Roberts M; Abrams B; Zhou W; Looby M; Kaiser G; Hamed K
    Antimicrob Agents Chemother; 2009 May; 53(5):1912-20. PubMed ID: 19273678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose pharmacokinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children.
    Blumer J; Rodriguez A; Sánchez PJ; Sallas W; Kaiser G; Hamed K
    Antimicrob Agents Chemother; 2010 May; 54(5):2032-41. PubMed ID: 20160046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famciclovir/penciclovir.
    Sacks SL; Wilson B
    Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes simplex virus infection.
    Whitley RJ
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Wagstaff AJ
    Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famciclovir: review of clinical efficacy and safety.
    Cirelli R; Herne K; McCrary M; Lee P; Tyring SK
    Antiviral Res; 1996 Mar; 29(2-3):141-51. PubMed ID: 8739594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
    Simpson D; Lyseng-Williamson KA
    Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological profile of famciclovir.
    Crumpacker C
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):14-26. PubMed ID: 8840412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers.
    Pue MA; Pratt SK; Fairless AJ; Fowles S; Laroche J; Georgiou P; Prince W
    J Antimicrob Chemother; 1994 Jan; 33(1):119-27. PubMed ID: 8157552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Famciclovir: a focus on efficacy and safety.
    Mubareka S; Leung V; Aoki FY; Vinh DC
    Expert Opin Drug Saf; 2010 Jul; 9(4):643-58. PubMed ID: 20429777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
    Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D
    J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and pharmacokinetics of a single 1500-mg dose of famciclovir in adolescents with recurrent herpes labialis.
    Block SL; Yogev R; Waldmeier F; Hamed K
    Pediatr Infect Dis J; 2011 Jun; 30(6):525-8. PubMed ID: 21178655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
    Safrin S
    Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
    [No Abstract]   [Full Text] [Related]  

  • 15. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.
    Schacker T; Hu HL; Koelle DM; Zeh J; Saltzman R; Boon R; Shaughnessy M; Barnum G; Corey L
    Ann Intern Med; 1998 Jan; 128(1):21-8. PubMed ID: 9424977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing.
    Alster TS; Nanni CA
    Dermatol Surg; 1999 Mar; 25(3):242-6. PubMed ID: 10193975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
    Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
    AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Drugs Against Alphaherpesvirus.
    Shiraki K
    Adv Exp Med Biol; 2018; 1045():103-122. PubMed ID: 29896665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of herpes simplex and varicella-zoster virus infections.
    Erlich KS
    West J Med; 1997 Mar; 166(3):211-5. PubMed ID: 9143202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
    Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.